Molecular Dynamics Simulations and Dynamic Network Analysis Reveal the Allosteric Unbinding of Monobody to H-Ras Triggered by R135K Mutation
The DOI matches its Crossref record; 17 of the 17 references it cites were found in a registry or an index.
Abstract
Ras proteins, as small GTPases, mediate cell proliferation, survival and differentiation. Ras mutations have been associated with a broad spectrum of human cancers and thus targeting Ras represents a potential way forward for cancer therapy. A recently reported monobody NS1 allosterically disrupts the Ras-mediated signaling pathway, but its efficacy is reduced by R135K mutation in H-Ras. However, the detailed mechanism is unresolved. Here, using molecular dynamics (MD) simulations and dynamic network analysis, we explored the molecular mechanism for the unbinding of NS1 to H-Ras and shed light on the underlying allosteric network in H-Ras. MD simulations revealed that the overall structures of the two complexes did not change significantly, but the H-Ras–NS1 interface underwent significant conformational alteration in the mutant Binding free energy analysis showed that NS1 binding was unfavored after R135K mutation, which resulted in the unfavorable binding of NS1. Furthermore, the critical residues on H-Ras responsible for the loss of binding of NS1 were identified. Importantly, the allosteric networks for these important residues were revealed, which yielded a novel insight into the allosteric regulatory mechanism of H-Ras.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Indeed, both computational and experimental methods have successfully elucidated allosteric pathways in a variety of different systems outside of protein kinase A45–52.”
From Defective internal allosteric network imparts dysfunctional ATP/substrate-binding cooperativity in oncogenic chimera of protein kinase A (2021) · cites this paper as [50]
In the citing paper
“Perhaps more importantly, many of these studies have shown how disruptions in these pathways act to change function.”
From Defective internal allosteric network imparts dysfunctional ATP/substrate-binding cooperativity in oncogenic chimera of protein kinase A (2021) · cites this paper as [50]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
K-Ras(G12C) inhibitors allosterically control GTP affinity and effector interactions
Ostrem, J. M., Peters, U., Sos, M. L., Wells, J. A., & Shokat, K. M. (2013) · Nature · doi:10.1038/nature12796 · Cited by 2,557
A Comprehensive Survey of Ras Mutations in Cancer
Prior, I. A., Lewis, P. D., & Mattos, C. (2012) · Cancer Research · doi:10.1158/0008-5472.can-11-2612 · Cited by 2,063
RAS oncogenes: weaving a tumorigenic web
Pylayeva-Gupta, Y., Grabocka, E., & Bar-Sagi, D. (2011) · Nature Reviews Cancer · doi:10.1038/nrc3106 · Cited by 1,789
Ras oncogenes: split personalities
Karnoub, A. E., & Weinberg, R. A. (2008) · Nature Reviews Molecular Cell Biology · doi:10.1038/nrm2438 · Cited by 1,467 · cited 1×
“Ras proteins, a series of GTPases [1], play key roles in the regulation of cell proliferation, cell survival as well as cell motility [2,3], and thus are closely related to tumorigenesis [4–9].”
BackgroundRas history: The saga continues
Cox, A. D., & Der, C. J. (2010) · Small GTPases · doi:10.4161/sgtp.1.1.12178 · Cited by 706
Ras Conformational Ensembles, Allostery, and Signaling
Lu, S., Jang, H., Muratcioglu, S., Gursoy, A., Keskin, O., Nussinov, R., & Zhang, J. (2016) · Chemical Reviews · doi:10.1021/acs.chemrev.5b00542 · Cited by 355
Self-citationGenetic analysis of Ras signalling pathways in cell proliferation, migration and survival
Drosten, M., Dhawahir, A., Sum, E. Y. M., Urosevic, J., Lechuga, C. G., Esteban, L. M., Castellano, E., Guerra, C., Santos, E., & Barbacid, M. (2010) · The EMBO Journal · doi:10.1038/emboj.2010.7 · Cited by 347 · cited 1×
“Ras proteins, a series of GTPases [1], play key roles in the regulation of cell proliferation, cell survival as well as cell motility [2,3], and thus are closely related to tumorigenesis [4–9].”
BackgroundInhibition of RAS function through targeting an allosteric regulatory site
Spencer-Smith, R., Koide, A., Zhou, Y., Eguchi, R. R., Sha, F., Gajwani, P., Santana, D., Gupta, A., Jacobs, M., Herrero-Garcia, E., et al. (2017) · Nature Chemical Biology · doi:10.1038/nchembio.2231 · Cited by 283
Ras-GTP dimers activate the Mitogen-Activated Protein Kinase (MAPK) pathway
Nan, X., Tamgüney, T. M., Collisson, E. A., Lin, L.-J., Pitt, C., Galeas, J., Lewis, S., Gray, J. W., McCormick, F., & Chu, S. (2015) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1509123112 · Cited by 273 · cited 1×
“In their active forms, Ras-GTP complexes can form dimers with each other [24,32,33], which can subsequently recruit the Raf kinase.”
BackgroundThe Structural Basis of Oncogenic Mutations G12, G13 and Q61 in Small GTPase K-Ras4B
Lu, S., Jang, H., Nussinov, R., & Zhang, J. (2016) · Scientific Reports · doi:10.1038/srep21949 · Cited by 219
Self-citationYoung, A., Lou, D., & McCormick, F. (2013) · Cancer Discovery · doi:10.1158/2159-8290.cd-12-0231 · Cited by 211
GTP-Dependent K-Ras Dimerization
Muratcioglu, S., Chavan, T. S., Freed, B. C., Jang, H., Khavrutskii, L., Freed, R. N., Dyba, M. A., Stefanisko, K., Tarasov, S. G., Gursoy, A., et al. (2015) · Structure · doi:10.1016/j.str.2015.04.019 · Cited by 202 · cited 1×
“In their active forms, Ras-GTP complexes can form dimers with each other [24,32,33], which can subsequently recruit the Raf kinase.”
BackgroundDrugging Ras GTPase: a comprehensive mechanistic and signaling structural view
Lu, S., Jang, H., Gu, S., Zhang, J., & Nussinov, R. (2016) · Chemical Society Reviews · doi:10.1039/c5cs00911a · Cited by 188
Self-citationThe Design of Covalent Allosteric Drugs
Nussinov, R., & Tsai, C.-J. (2015) · Annual Review of Pharmacology and Toxicology · doi:10.1146/annurev-pharmtox-010814-124401 · Cited by 112
Inhibitors of Ras–SOS Interactions
Lu, S., Jang, H., Zhang, J., & Nussinov, R. (2016) · ChemMedChem · doi:10.1002/cmdc.201500481 · Cited by 72
Self-citationDruggable Orthosteric and Allosteric Hot Spots to Target Protein-protein Interactions
Ma, B., & Nussinov, R. (2014) · Current Pharmaceutical Design · doi:10.2174/13816128113199990073 · Cited by 45
RAS oncogenic signal upregulates EZH2 in pancreatic cancer
Fujii, S., Fukamachi, K., Tsuda, H., Ito, K., Ito, Y., & Ochiai, A. (2012) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2011.12.099 · Cited by 38
Research works printed but not linked: 46
- Tsai, 2014, The free energy landscape in translational science: How can somatic mutations result in constitutive oncogenic activation?, Phys. Chem. Chem. Phys., 16, 6332, 10.1039/c3cp54253j · DOI · Paper page
- Rajalingam, 2007, Ras oncogenes and their downstream targets, Biochim. Biophys. Acta, 1773, 1177, 10.1016/j.bbamcr.2007.01.012 · DOI · Paper page
- Jeantet, M., Tougeron, D., Tachon, G., Cortes, U., Archambaut, C., Fromont, G., and Karayan-Tapon, L. (2016). High Intra- and Inter-Tumoral Heterogeneity of RAS Mutations in Colorectal Cancer. Int. J. Mol. Sci., 17. · DOI · Paper page
- Nussinov, 2016, Independent and core pathways in oncogenic KRAS signaling, Expert Rev. Proteom., 13, 711, 10.1080/14789450.2016.1209417 · DOI
- Nussinov, 2016, A New View of Ras Isoforms in Cancers, Cancer Res., 76, 18, 10.1158/0008-5472.CAN-15-1536 · DOI · Paper page
- Nussinov, 2016, K-Ras4B/calmodulin/PI3Kα: A promising new adenocarcinoma-specific drug target?, Expert Opin. Ther. Targets, 20, 831, 10.1517/14728222.2016.1135131 · DOI
- Tomasini, P., Serdjebi, C., Khobta, N., Metellus, P., Ouafik, L., Nanni, I., Greillier, L., Loundou, A., Fina, F., and Mascaux, C. (2016). EGFR and KRAS Mutations Predict the Incidence and Outcome of Brain Metastases in Non-Small Cell Lung Cancer. Int. J. Mol. Sci., 17. · DOI
- Olmedillas Lopez, S., Garcia-Olmo, D.C., Garcia-Arranz, M., Guadalajara, H., Pastor, C., and Garcia-Olmo, D. (2016). KRAS G12V Mutation Detection by Droplet Digital PCR in Circulating Cell-Free DNA of Colorectal Cancer Patients. Int. J. Mol. Sci., 17. · DOI
- Lu, 2015, GTP Binding and Oncogenic Mutations May Attenuate Hypervariable Region (HVR)-Catalytic Domain Interactions in Small GTPase K-Ras4B, Exposing the Effector Binding Site, J. Biol. Chem., 290, 28887, 10.1074/jbc.M115.664755 · DOI · Paper page
- Csermely, 2016, Intracellular and intercellular signaling networks in cancer initiation, development and precision anti-cancer therapy: RAS acts as contextual signaling hub, Semin. Cell Dev. Biol., 58, 55, 10.1016/j.semcdb.2016.07.005 · DOI
- Chang, 1982, Human genome contains four genes homologous to transforming genes of Harvey and Kirsten murine sarcoma viruses, Proc. Natl. Acad. Sci. USA, 79, 4848, 10.1073/pnas.79.16.4848 · DOI · Paper page
- Banerjee, 2016, The disordered hypervariable region and the folded catalytic domain of oncogenic K-Ras4B partner in phospholipid binding, Curr. Opin. Struct. Biol., 36, 10, 10.1016/j.sbi.2015.11.010 · DOI · Paper page
- Ji, 2007, Oncogenic KRAS activates hedgehog signaling pathway in pancreatic cancer cells, J. Biol. Chem., 282, 14048, 10.1074/jbc.M611089200 · DOI · Paper page
- Xing, 2003, Pharmacologic inactivation of kinase suppressor of Ras-1 abrogates Ras-mediated pancreatic cancer, Nat. Med., 9, 1266, 10.1038/nm927 · DOI
- Eser, 2014, Oncogenic KRAS signalling in pancreatic cancer, Br. J. Cancer, 111, 817, 10.1038/bjc.2014.215 · DOI · Paper page
- Sekine, 2006, Hedgehog/Ras interactions regulate early stages of pancreatic cancer, Genes Dev., 20, 3161, 10.1101/gad.1470806 · DOI · Paper page
- Lu, 2014, Harnessing allostery: A novel approach to drug discovery, Med. Res. Rev., 34, 1245, 10.1002/med.21317 · DOI · Paper page
- Der, 1994, The Ras signal transduction pathway, Cancer Metastasis Rev., 13, 67, 10.1007/BF00690419 · DOI · Paper page
- Maiello, 2012, The RAS/RAF/MEK/ERK and the PI3K/AKT signalling pathways: Role in cancer pathogenesis and implications for therapeutic approaches, Expert Opin. Ther. Targets, 16, S17, 10.1517/14728222.2011.639361 · DOI · Paper page
- Chang, 2003, Signal transduction mediated by the Ras/Raf/MEK/ERK pathway from cytokine receptors to transcription factors: Potential targeting for therapeutic intervention, Leukemia, 17, 1263, 10.1038/sj.leu.2402945 · DOI · Paper page
- Cho, 2016, Computational Equilibrium Thermodynamic and Kinetic Analysis of K-Ras Dimerization through an Effector Binding Surface Suggests Limited Functional Role, J. Phys. Chem. B, 120, 8547, 10.1021/acs.jpcb.6b02403 · DOI
- Hall, 2002, The structural basis for the transition from Ras-GTP to Ras-GDP, Proc. Natl. Acad. Sci. USA, 99, 12138, 10.1073/pnas.192453199 · DOI · Paper page
- Buhrman, 2011, Allosteric modulation of Ras-GTP is linked to signal transduction through RAF kinase, J. Biol. Chem., 286, 3323, 10.1074/jbc.M110.193854 · DOI · Paper page
- Grant, B.J., Lukman, S., Hocker, H.J., Sayyah, J., Brown, J.H., McCammon, J.A., and Gorfe, A.A. (2011). Novel allosteric sites on Ras for lead generation. PLoS ONE, 6. · DOI · Paper page
- Zhuang, 2016, Interactions of benzotriazole UV stabilizers with human serum albumin: Atomic insights revealed by biosensors, spectroscopies and molecular dynamics simulations, Chemosphere, 144, 1050, 10.1016/j.chemosphere.2015.09.085 · DOI
- Ding, 2015, Atomic-scale investigation of the interactions between tetrabromobisphenol A, tetrabromobisphenol S and bovine trypsin by spectroscopies and molecular dynamics simulations, J. Hazard. Mater., 299, 486, 10.1016/j.jhazmat.2015.07.050 · doi:10.1016/j.jhazmat.2015.07.050
- Alred, 2014, Stability of Iowa mutant and wild type Abeta-peptide aggregates, J. Chem. Phys., 141, 175101, 10.1063/1.4900892 · DOI
- Clausen, R., Ma, B., Nussinov, R., and Shehu, A. (2015). Mapping the Conformation Space of Wildtype and Mutant H-Ras with a Memetic, Cellular, and Multiscale Evolutionary Algorithm. PLoS Comput. Biol., 11. · DOI · Paper page
- Sun, H., Li, Y., Tian, S., Wang, J., and Hou, T. (2014). P-loop conformation governed crizotinib resistance in G2032R-mutated ROS1 tyrosine kinase: Clues from free energy landscape. PLoS Comput. Biol., 10. · DOI · Paper page
- Nussinov, 2014, The structural basis for cancer treatment decisions, Oncotarget, 5, 7285, 10.18632/oncotarget.2439 · DOI · Paper page
- Dror, 2012, Biomolecular simulation: A computational microscope for molecular biology, Annu. Rev. Biophys., 41, 429, 10.1146/annurev-biophys-042910-155245 · DOI · Paper page
- Bermudez, 2016, More than a look into a crystal ball: Protein structure elucidation guided by molecular dynamics simulations, Drug Discov. Today, 21, 1799, 10.1016/j.drudis.2016.07.001 · DOI
- Gkeka, P., Evangelidis, T., Pavlaki, M., Lazani, V., Christoforidis, S., Agianian, B., and Cournia, Z. (2014). Investigating the structure and dynamics of the PIK3CA wild-type and H1047R oncogenic mutant. PLoS Comput. Biol., 10. · DOI · Paper page
- Lu, 2015, The Mechanism of ATP-Dependent Allosteric Protection of Akt Kinase Phosphorylation, Structure, 23, 1725, 10.1016/j.str.2015.06.027 · DOI · Paper page
- Blacklock, K., and Verkhivker, G.M. (2014). Computational modeling of allosteric regulation in the hsp90 chaperones: A statistical ensemble analysis of protein structure networks and allosteric communications. PLoS Comput. Biol., 10. · DOI · Paper page
- Lu, S., Huang, W., Wang, Q., Shen, Q., Li, S., Nussinov, R., and Zhang, J. (2014). The structural basis of ATP as an allosteric modulator. PLoS Comput. Biol., 10. · DOI · Paper page
- Sun, 2015, Revealing the favorable dissociation pathway of type II kinase inhibitors via enhanced sampling simulations and two-end-state calculations, Sci. Rep., 5, 8457, 10.1038/srep08457 · DOI
- Liu, 2015, Insights into the key interactions between human protein phosphatase 5 and cantharidin using molecular dynamics and site-directed mutagenesis bioassays, Sci. Rep., 5, 12359, 10.1038/srep12359 · DOI
- Krissinel, 2007, Inference of macromolecular assemblies from crystalline state, J. Mol. Biol., 372, 774, 10.1016/j.jmb.2007.05.022 · DOI · Paper page
- Eargle, 2012, NetworkView: 3D display and analysis of protein. RNA interaction networks, Bioinformatics, 28, 3000, 10.1093/bioinformatics/bts546 · DOI · Paper page
- Berman, 2000, The Protein Data Bank, Nucleic Acids Res., 28, 235, 10.1093/nar/28.1.235 · DOI · Paper page
- York, 1994, Atomic-level accuracy in simulations of large protein crystals, Proc. Natl. Acad. Sci. USA, 91, 8715, 10.1073/pnas.91.18.8715 · DOI · Paper page
- Case, 2005, The Amber biomolecular simulation programs, J. Comput. Chem., 26, 1668, 10.1002/jcc.20290 · DOI · Paper page
- Lu, 2017, Designed covalent allosteric modulators: An emerging paradigm in drug discovery, Drug Discov. Today, 22, 447, 10.1016/j.drudis.2016.11.013 · DOI
- Wilson, 2016, Recent advances in cancer drug discovery targeting RAS, Drug Discov. Today, 21, 1915, 10.1016/j.drudis.2016.08.002 · DOI
- Jiang, 2017, Peptidomimetic inhibitors of APC-Asef interaction block colorectal cancer migration, Nat. Chem. Biol., 13, 994, 10.1038/nchembio.2442 · DOI
Cited by
Drugging K-RasG12C through covalent inhibitors: Mission possible?
Ni, D., Li, X., He, X., Zhang, H., Zhang, J., & Lu, S. (2019) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2019.06.007 · Cited by 73
Self-citationOlivieri, C., Walker, C., Karamafrooz, A., Wang, Y., Manu, V. S., Porcelli, F., Blumenthal, D. K., Thomas, D. D., Bernlohr, D. A., Simon, S. M., et al. (2021) · Communications Biology · doi:10.1038/s42003-021-01819-6 · Cited by 27
Metadata
- Authors
- Ni, D., Song, K., Zhang, J., & Lu, S.
- Venue
- International Journal of Molecular Sciences
- Publisher
- MDPI AG
- Published
- 2017-10-26
- Volume
- 18
- Issue
- 11
- Pages
- 2249
- ISSN
- 1422-0067
- Cited by
- 29
- References
- 17
- Language
- en
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.